Adenosquamous Carcinoma of the Endometrium - 9 Studies Found
| Active, not recruiting |
: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer :
|
| Recruiting |
: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer :
|
| Completed |
: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer :
|
| Recruiting |
: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer :
|
| Active, not recruiting |
: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer :
|
| Active, not recruiting |
: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer :
|
| Completed |
: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer :
|
| Active, not recruiting |
: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer :
|
| Completed |
: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus :
|